374 related articles for article (PubMed ID: 17620653)
1. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
[TBL] [Abstract][Full Text] [Related]
2. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma.
Kamihira S; Yamada Y; Sohda H; Atogami S; Tomonaga M; Egawa S; Fujii M; Chifu K
Cancer Detect Prev; 1994; 18(5):329-34. PubMed ID: 7812978
[TBL] [Abstract][Full Text] [Related]
4. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanism for positive interaction of human T cell leukemia type I on liver disease in a hepatitis C virus-infected Japanese cohort.
Casseb J
J Infect Dis; 2000 Jul; 182(1):379-80. PubMed ID: 10882633
[No Abstract] [Full Text] [Related]
8. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China.
Wang Y; Li X; Song A; Zhang C; Chen Y; Chen C; Lin Y; Shun L; Li L; Liu Y; Yang J; Yang B; Tang Q; Harrison TJ
J Med Virol; 2005 Aug; 76(4):613-8. PubMed ID: 15977241
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic.
Nobre V; Guedes AC; Proietti FA; Martins ML; Nassif G; Serufo JC; Lambertucci JR;
Intervirology; 2007; 50(4):316-8. PubMed ID: 17622792
[TBL] [Abstract][Full Text] [Related]
11. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
[TBL] [Abstract][Full Text] [Related]
12. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
[TBL] [Abstract][Full Text] [Related]
13. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
14. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.
Boschi-Pinto C; Stuver S; Okayama A; Trichopoulos D; Orav EJ; Tsubouchi H; Mueller N
J Infect Dis; 2000 Jan; 181(1):35-41. PubMed ID: 10608748
[TBL] [Abstract][Full Text] [Related]
15. Leprosy and confinement due to leprosy show high association with hepatitis C in Southern Brazil.
de Moraes Braga AC; Reason IJ; Maluf EC; Vieira ER
Acta Trop; 2006 Jan; 97(1):88-93. PubMed ID: 16263074
[TBL] [Abstract][Full Text] [Related]
16. Epidemic patterns of hepatitis type B virus (HBV) and human T lymphotropic virus type I (HTLV-I) in two ATL-endemic islands in Kyushu, Japan.
Tachibana K; Ito S; Shirahama S; Nagatomo M; Kinoshita K; Tajima K
Nagoya J Med Sci; 1991 Mar; 53(1-4):23-32. PubMed ID: 1805134
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru.
Verdonck K; González E; Henostroza G; Nabeta P; Llanos F; Cornejo H; Vanham G; Seas C; Gotuzzo E
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1066-72. PubMed ID: 17945062
[TBL] [Abstract][Full Text] [Related]
19. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
20. Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
Sagara Y; Inoue Y; Tsujimura M; Kojima E; Shiraki H; Kashiwagi S
Cancer Sci; 2004 Oct; 95(10):835-9. PubMed ID: 15504252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
